| 1 |
Gao X, Kang J, Li X, Chen C, Luo D. Deletion of the tyrosine phosphatase Shp2 in cervical cancer cells promotes reprogramming of glutamine metabolism. FASEB J 2023;37:e22880. [PMID: 36943407 DOI: 10.1096/fj.202202078RR] [Reference Citation Analysis]
|
| 2 |
Sampaio-Dias IE, Santejo M, Silva-Reis SC, Liz MA, Alcoholado C, Algarra M, García-Mera X, Rodríguez-Borges JE. Design, Synthesis, and Biological Evaluation of Hybrid Glypromate Analogues Using 2-Azanorbornane as a Prolyl and Pipecolyl Surrogate. ACS Chem Neurosci 2021;12:3615-24. [PMID: 34515466 DOI: 10.1021/acschemneuro.1c00339] [Reference Citation Analysis]
|
| 3 |
Srivastava R, Choudhury PK, Dev SK, Rathore V. Neuroprotective effect of α-pinene self-emulsifying nanoformulation against 6-OHDA induced neurotoxicity on human SH-SY5Y cells and its in vivo validation for anti-Parkinson's effect. J Biochem Mol Toxicol 2021;35:e22902. [PMID: 34464010 DOI: 10.1002/jbt.22902] [Reference Citation Analysis]
|
| 4 |
Sampaio-Dias IE, Reis-Mendes A, Costa VM, García-Mera X, Brea J, Loza MI, Pires-Lima BL, Alcoholado C, Algarra M, Rodríguez-Borges JE. Discovery of New Potent Positive Allosteric Modulators of Dopamine D2 Receptors: Insights into the Bioisosteric Replacement of Proline to 3-Furoic Acid in the Melanostatin Neuropeptide. J Med Chem 2021;64:6209-20. [PMID: 33861612 DOI: 10.1021/acs.jmedchem.1c00252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Dirks WG, Capes-Davis A, Eberth S, Fähnrich S, Wilting J, Nagel S, Steenpass L, Becker J. Cross contamination meets misclassification: Awakening of CHP-100 from sleeping beauty sleep-A reviewed model for Ewing's sarcoma. Int J Cancer 2021. [PMID: 33460449 DOI: 10.1002/ijc.33474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Silva J, Alves C, Pinteus S, Mendes S, Pedrosa R. Seaweeds' neuroprotective potential set in vitro on a human cellular stress model. Mol Cell Biochem 2020;473:229-38. [PMID: 32656679 DOI: 10.1007/s11010-020-03824-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 7 |
Wang T, Ye X, Bian W, Chen Z, Du J, Li M, Zhou P, Cui H, Ding YQ, Qi S, Liao M, Sun C. Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage. Front Cell Neurosci 2019;13:569. [PMID: 31998078 DOI: 10.3389/fncel.2019.00569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 8 |
Ko YH, Kwon SH, Kim SK, Lee BR, Hur KH, Kim YJ, Kim SE, Lee SY, Jang CG. Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells. Arch Pharm Res 2019;42:1081-91. [PMID: 31705299 DOI: 10.1007/s12272-019-01191-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 9 |
Abdulla ZI, Pahlevani B, Lundgren KH, Pennington JL, Udobi KC, Seroogy KB, Skelton MR. Deletion of the Creatine Transporter (Slc6a8) in Dopaminergic Neurons Leads to Hyperactivity in Mice. J Mol Neurosci 2020;70:102-11. [PMID: 31520365 DOI: 10.1007/s12031-019-01405-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Eo H, Kwon Y, Huh E, Sim Y, Choi JG, Jeong JS, Du XF, Soh HY, Hong SP, Kim Pak Y, Oh MS. Protective effects of DA-9805 on dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity in the models of Parkinson's disease. Biomed Pharmacother 2019;117:109184. [PMID: 31387167 DOI: 10.1016/j.biopha.2019.109184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 11 |
Camargo A, Rodrigues ALS. Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators. Chronic Stress (Thousand Oaks) 2019;3:2470547019858083. [PMID: 32440595 DOI: 10.1177/2470547019858083] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 12 |
Pazini FL, Cunha MP, Rodrigues ALS. The possible beneficial effects of creatine for the management of depression. Prog Neuropsychopharmacol Biol Psychiatry 2019;89:193-206. [PMID: 30193988 DOI: 10.1016/j.pnpbp.2018.08.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 13 |
Liu Y, Deng Z, Geng L, Wang J, Zhang Q. In vitro evaluation of the neuroprotective effect of oligo-porphyran from Porphyra yezoensis in PC12 cells. J Appl Phycol 2019;31:2559-71. [DOI: 10.1007/s10811-018-1713-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Martins IK, de Carvalho NR, Macedo GE, Rodrigues NR, Ziech CC, Vinadé L, Filho VMB, Menezes IA, Franco J, Posser T. Anacardium microcarpum Promotes Neuroprotection Dependently of AKT and ERK Phosphorylation but Does Not Prevent Mitochondrial Damage by 6-OHDA. Oxid Med Cell Longev 2018;2018:2131895. [PMID: 30510616 DOI: 10.1155/2018/2131895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 15 |
Cunha MP, Pazini FL, Lieberknecht V, Rodrigues ALS. Subchronic administration of creatine produces antidepressant-like effect by modulating hippocampal signaling pathway mediated by FNDC5/BDNF/Akt in mice. J Psychiatr Res 2018;104:78-87. [PMID: 30005372 DOI: 10.1016/j.jpsychires.2018.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 16 |
Calabrese V, Santoro A, Trovato Salinaro A, Modafferi S, Scuto M, Albouchi F, Monti D, Giordano J, Zappia M, Franceschi C, Calabrese EJ. Hormetic approaches to the treatment of Parkinson's disease: Perspectives and possibilities. J Neurosci Res 2018;96:1641-62. [PMID: 30098077 DOI: 10.1002/jnr.24244] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 17 |
Fortalezas S, Marques-da-Silva D, Gutierrez-Merino C. Creatine Protects Against Cytosolic Calcium Dysregulation, Mitochondrial Depolarization and Increase of Reactive Oxygen Species Production in Rotenone-Induced Cell Death of Cerebellar Granule Neurons. Neurotox Res 2018;34:717-32. [PMID: 30094708 DOI: 10.1007/s12640-018-9940-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Abdulla ZI, Pahlevani B, Pennington JL, Latushka N, R. Skelton M. Deletion of the Creatine Transporter in dopaminergic neurons leads to hyperactivity in mice.. [DOI: 10.1101/293563] [Reference Citation Analysis]
|
| 19 |
Silva J, Alves C, Pinteus S, Mendes S, Pedrosa R. Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model. BMC Complement Altern Med 2018;18:58. [PMID: 29444677 DOI: 10.1186/s12906-018-2103-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 20 |
Wu HC, Hu QL, Zhang SJ, Wang YM, Jin ZK, Lv LF, Zhang S, Liu ZL, Wu HL, Cheng OM. Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein. Neural Regen Res 2018;13:1375-83. [PMID: 30106049 DOI: 10.4103/1673-5374.235250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 21 |
Romero A, Parada E, González-Lafuente L, Farré-Alins V, Ramos E, Cacabelos R, Egea J. Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®). CNS Neurosci Ther 2017;23:450-2. [PMID: 28371323 DOI: 10.1111/cns.12693] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Chamberlain KA, Chapey KS, Nanescu SE, Huang JK. Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating Injury. J Neurosci 2017;37:1479-92. [PMID: 28069926 DOI: 10.1523/JNEUROSCI.1941-16.2016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 23 |
Cunha MP, Lieberknecht V, Ramos-Hryb AB, Olescowicz G, Ludka FK, Tasca CI, Gabilan NH, Rodrigues AL. Creatine affords protection against glutamate-induced nitrosative and oxidative stress. Neurochem Int 2016;95:4-14. [PMID: 26804444 DOI: 10.1016/j.neuint.2016.01.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 24 |
Sestili P, Ambrogini P, Barbieri E, Sartini S, Fimognari C, Calcabrini C, Diaz AR, Guescini M, Polidori E, Luchetti F, Canonico B, Lattanzi D, Cuppini R, Papa S, Stocchi V. New insights into the trophic and cytoprotective effects of creatine in in vitro and in vivo models of cell maturation. Amino Acids 2016;48:1897-911. [DOI: 10.1007/s00726-015-2161-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 25 |
Pazini FL, Cunha MP, Rosa JM, Colla AR, Lieberknecht V, Oliveira Á, Rodrigues AL. Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway. Mol Neurobiol 2016;53:6818-34. [PMID: 26660117 DOI: 10.1007/s12035-015-9580-9] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 26 |
Cunha MP, Budni J, Ludka FK, Pazini FL, Rosa JM, Oliveira Á, Lopes MW, Tasca CI, Leal RB, Rodrigues ALS. Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine. Mol Neurobiol 2016;53:2954-68. [PMID: 25943184 DOI: 10.1007/s12035-015-9192-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 27 |
Chavarria D, Silva T, Martins D, Bravo J, Summavielle T, Garrido J, Borges F. Exploring cinnamic acid scaffold: development of promising neuroprotective lipophilic antioxidants. Med Chem Commun 2015;6:1043-53. [DOI: 10.1039/c5md00018a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 28 |
Cunha MP, Martín-de-Saavedra MD, Romero A, Egea J, Ludka FK, Tasca CI, Farina M, Rodrigues AL, López MG. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model. ASN Neuro 2014;6:1759091414554945. [PMID: 25424428 DOI: 10.1177/1759091414554945] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 29 |
Kwon S, Ma S, Lee S, Jang C. Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells. Neurochemistry International 2014;74:53-64. [DOI: 10.1016/j.neuint.2014.04.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 30 |
Qu L, Wang Y, Zhang H, Li N, Wang Q, Yang Q, Gao G, Wang X. 6-OHDA induced calcium influx through N-type calcium channel alters membrane properties via PKA pathway in substantia nigra pars compacta dopaminergic neurons. Neuroscience Letters 2014;575:1-6. [DOI: 10.1016/j.neulet.2014.05.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 31 |
Chen S, An F, Yin L, Liu A, Yin D, Yao W, Gao X. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation. Neuroscience 2014;256:137-46. [DOI: 10.1016/j.neuroscience.2013.10.038] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 32 |
Meng XB, Sun GB, Wang M, Sun J, Qin M, Sun XB. P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells. Evid Based Complement Alternat Med 2013;2013:971712. [PMID: 24159358 DOI: 10.1155/2013/971712] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
